Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Segment Information (Details)

v3.22.4
Segment Information (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
segment
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Segment Reporting Information [Line Items]      
Number of operating segments | segment 2    
Net revenue:      
Total net revenue $ 509,728 $ 484,329 $ 444,448
Cost of revenue:      
Cost of revenue 321,832 297,269 258,555
Gross profit:      
GROSS PROFIT 187,896 187,060 185,893
Operating expenses:      
General and administrative 243,356 221,347 143,794
Research and development 30,326 21,873 8,229
Sales and marketing 67,321 62,594 47,862
Restructuring charges 4,516 0 0
Total operating expenses 345,519 305,814 199,885
LOSS FROM OPERATIONS (157,623) (118,754) (13,992)
Interest expense, net 1,506 5,082 7,019
Other expense (income), net 213 499 (7,906)
Gain on investment in and loan receivable from non-consolidated affiliate, net 0 (109,260) (3,955)
Loss on debt extinguishment 0 0 1,400
Loss on termination of cash flow hedge 0 0 3,506
Loss before taxes (159,342) (15,075) (14,056)
Income tax benefit (15,092) (6,728) (18,228)
NET (LOSS) INCOME (144,250) (8,347) 4,172
Clinical Services      
Net revenue:      
Total net revenue 418,754 404,172 382,337
Cost of revenue:      
Cost of revenue 261,742 244,360 215,529
Gross profit:      
GROSS PROFIT 157,012 159,812 166,808
Clinical Services | Amortization of acquired developed technology intangible assets      
Cost of revenue:      
Cost of revenue 17,100 9,200  
Clinical Services | Write Off For COVID-19 PCR Testing Inventory      
Cost of revenue:      
Cost of revenue 5,300    
Pharma Services      
Net revenue:      
Total net revenue 90,974 80,157 62,111
Cost of revenue:      
Cost of revenue 60,090 52,909 43,026
Gross profit:      
GROSS PROFIT 30,884 27,248 $ 19,085
Pharma Services | Amortization of acquired developed technology intangible assets      
Cost of revenue:      
Cost of revenue $ 2,400 $ 1,200